Fresenius Medical Care Earnings Beat Expectations, but Contraction Awaits
Dow Jones
Aug 04
0523 GMT - Fresenius Medical Care's second-quarter results beat consensus expectations, but the company's reiteration of full-year guidance suggests earnings are likely to contract in coming quarters, J.P. Morgan analysts say in a research note. The German dialysis specialist reported a quarterly adjusted operating profit of 569 million euros, ahead of consensus estimates of 514 million euros. This probably has more to do with how analysts modeled the timing of effects of Medicare payment adjustments, which also explains why Fresenius Medical Care reiterated 2026 guidance, according to JPM. The company's outlook points to an earnings contraction in the mid-teens to mid-20s percentage range in the second half, the analysts say.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.